The goal of this session is to prepare learners to evaluate for, prevent, and manage cardio-metabolic complications in people with HIV (PWH). The session exemplifies team-based approaches to chronic disease management.
By the end of the module, the learner will be able to:
- Identify common cardiovascular disease risk factors among people with HIV (PWH)
- Recognize the role of risk prediction tools to optimize cardiovascular disease (CVD) prevention
- Discuss recommendations to optimize the patient’s cardiovascular health
- Identify drug-drug interactions between Antiretroviral Therapy and pharmacologic agents used to prevent and treat cardio-metabolic conditions
- Discuss team-based approaches to manage PWH with established CVD (IPE)
- Recognize the negative impact of CVD on long-term outcomes of PWH
- Appreciate other non-communicable diseases experienced by PWH.
Optimizing Team-Based Care to Achieve High Quality HIV Care
Central to this module, facilitators should prompt all learners to consider how they can deliver care that fosters optimized team-based care to ensure high quality HIV care. Consider how the case enables learners to gain greater competency in the following domains:
- Values and ethics: Work with individuals of other professions to maintain a climate of mutual respect and shared values.
- Roles/responsibilities: Use the knowledge of one’s own role and those of other professions to appropriately assess and address the health care needs of patients and to promote and advance the health of populations.
- Interprofessional Communication: Communicate with patients, families, communities, and professionals in health and other fields in a responsive and responsible manner that supports a team approach to the promotion and maintenance of health and the prevention and treatment of disease.
- Teams and Teamwork: Apply the values and principles of team dynamics to build relationships and perform effectively in different team roles to plan, deliver and evaluate person-centered care and population health programs and policies that are safe, timely, efficient, effective and equitable.
ART Antiretroviral therapy
BMI Body mass index BP Blood pressure
CVD Cardiovascular disease
FBS Fasting blood sugar
HIV Human Immunodeficiency Virus
HIV RNA HIV ribonucleic acid or HIV viral load
INSTI Integrase strand transferase inhibitor
NCD Non-communicable disease
PI Protease inhibitor
PWH People with HIV
SBP Systolic blood pressure
WHO World Health Organization